RAPP
RapportยทNASDAQ
--
--(--)
--
--(--)
RAPP Profile
Rapport Therapeutics, Inc.
A biopharmaceutical company focused on developing small molecule drugs for precise treatment of neurological diseases
1325 Boylston Street, Suite 401 Boston, MA 02215
--
Rapport Therapeutics, Inc., was incorporated under the laws of Delaware in February 2022 as Precision Neuroscience NewCo, Inc., and changed its name to Rapport Therapeutics, Inc. in October 2022. The Company is a clinical-stage biopharmaceutical company focused on becoming a leader in precision neuroscience through the discovery and development of translational small molecule drugs for patients with central nervous system (" CNS ") diseases.
